NO与2型糖尿病内皮祖细胞功能异常的关系
被引量:1
摘要
2型糖尿病(Type 2 Diabetes Mellitus,T2DM)是由行为、环境和遗传等多因素引起的一组以高血糖为临床标志的代谢综合征,患者常并发有血管闭塞性疾病,如冠状动脉粥样硬化、脑血管疾病、周围血管疾病及血管内皮功能受损。越来越多的证据显示,
出处
《中国现代医药杂志》
2013年第12期118-120,共3页
Modern Medicine Journal of China
参考文献19
-
1Hamed S,Brenner B,Abassi Z. Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus[J].{H}Thrombosis research,2010,(03):166-174.
-
2Asahara T,Murohara T,Sullivan A. Isolation of putative progenitor endothelial cells for angiogenesis[J].{H}SCIENCE,1997,(5302):964-967.
-
3Booth GL,Kapral MK,Fung K. Recent trends in cardiovascular complications among men and women with and without diabetes[J].{H}DIABETES CARE,2006,(01):32-37.
-
4刘华伟,王丽莉,刘庆君,诸葛欣,肖广辉.2型糖尿病患者外周血内皮祖细胞数量变化及机制探讨[J].天津医科大学学报,2013,19(4):323-325. 被引量:6
-
5Fadini GP,Miorin M,Facco M. Circuating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus[J].{H}Journal of the America College of Cardiology,2005,(09):1449-1457.
-
6Fadini GP,Sartore S,Albiero M. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy[J].{H}Arteriosclerosis Thrombosis and Vasoular Biology,2006,(09):2140-2146.
-
7Morello F,Perino A,Hirsch E. Phosphoinositide 3-kinase signalling in the vascular system[J].{H}Cardiovascular Research,2009,(02):261-271.
-
8Hoang HH,Padgham SV,Meininger CJ. L-arginine,tetrahydrobiopterin,nitric oxide and diabetes[J].{H}Current Opinion in Clinical Nutrition and Metabolic Care,2013,(01):76-82.
-
9Bauersachs J,Schafer A. Tetrahydrobiopterin and eNOS dimer/ monomer ratio-a clue to eNOS uncoupling in diabetes[J].{H}Cardiovascular Research,2005,(04):768-769.
-
10Segal MS,Shah R,Mzal A. Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes[J].{H}DIABETES,2006,(01):102-109.
二级参考文献12
-
1Asahara T, Murohara T, Sullivan A, et al. Isolation of putative pro- genitor endothelial cells for angiogenesis[J]. Science, 1997, 275 ( 5302 ):964.
-
2Liew A, McDermott J H, Barry F, et al. Endothelial progenitor cells for the treatment of diabetic vasculopathy: panacea or Pandora's box[J]. Diabetes Obes Metab, 2008, 10(5 ): 353.
-
3Avogaro A, de Kreutzenberg S V, Fadini G. Endothelial dysfunc- tion: causes and consequences in patients with diabetes mellitus[J]. Diabetes Res Clin Pract, 2008, 82 (Suppl 2):$94.
-
4Isabelle P, David J, Shahin R. The SD-1/CXCR4 ignaling pathway: a molecular hub modulating neoangiogesis[J]. Trends Immunol, 2007, 28(7): 299.
-
5Churdchomjan W, Kheolamai P, Manochantr S, et al. Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control[J]. BMC Endocrine Disorders, 2010,10:5.
-
6Fadini G P, Miorin M, Facco M, et al. Circulating endothelial pro- genitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus[J]. J Am Coll Cardiol, 2005, 45 (9):1449.
-
7Du X L, Edelstein D, Dimmeler S, et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational mod- ification at the Akt site[J]. J Clin Invest, 2001, 108(9):1341.
-
8Ho F M, Lin W W, Chen B C, et al. High glucose-induced apopto- sis in human vascular endothelial ceils is mediated through NF- kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway[J]. Cell Signal, 2006, 18 (3):391.
-
9Kc S, Carcamo J M, Golde D W. Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glutl) and confers mitochondri- al protection against oxidative injury[J]. FASEB J, 2005, 19( 12): 1657.
-
10Callaghan M J, Ceradini D J, Gunner G C. Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function[J]. Antioxid Redox Signal, 2005, 7 ( 11-12 ): 1476.
共引文献5
-
1周碧芸.糖尿病视网膜病变患者外周血内皮祖细胞数量的变化分析[J].吉林医学,2014,35(20):4473-4474. 被引量:1
-
2黎金凤,林安华,邓颖,霍亚南,刘精东,吴明斌,王晨秀.SDF-1对糖尿病外周血EPCs功能的影响及其与PI3K/AKT信号通路的关系[J].天津医药,2014,42(11):1069-1072. 被引量:3
-
3云苏日娜,孟根杜希,包玉龙,张冲,哈申图雅,包纳日斯,纳顺达来.内皮祖细胞在动脉粥样硬化临床中的应用[J].中国医药导报,2015,12(4):165-168. 被引量:2
-
4罗洁,李济金,胡春华.IGF-1和TGF-β1与糖尿病视网膜病变关系的研究[J].中国医药科学,2015,5(15):153-155. 被引量:5
-
5高静,李晓岚,王敏哲,刘贯英,杨雪松.血管内皮生长因子、基质细胞衍生因子-1基因对人微血管内皮细胞增殖、迁移、凋亡的影响[J].安徽医药,2019,23(9):1784-1789. 被引量:18
同被引文献12
-
1翟斐,李素梅.胰岛素抵抗与血管内皮功能障碍共同发病机制的研究进展[J].国际内科学杂志,2008,35(7):390-393. 被引量:10
-
2张京华,甄仲.精神分裂症与代谢综合征相关进展[J].医学综述,2012,18(21):3650-3652. 被引量:6
-
3梅力,易正辉.精神分裂症伴发代谢综合征的防治研究进展[J].中国神经精神疾病杂志,2014,40(7):443-446. 被引量:34
-
4李东风,章秋,刘桂,郑丽丽,吴晓静,余万庆.精神分裂症与代谢综合征的相关性研究[J].中国全科医学,2014,17(34):4083-4086. 被引量:22
-
5柏林,张国玲,高淑英,杨贵梅,梅静.常用非典型抗精神病药物与首发精神分裂症患者代谢综合征的相关性研究[J].河北医学,2015,21(1):151-154. 被引量:24
-
6吴莉珍.利培酮与氯氮平对精神分裂症患者体质量及糖脂代谢的影响[J].临床心身疾病杂志,2015,21(2):6-8. 被引量:10
-
7周海平,钟远惠,李桂云,付美华.利培酮与氯氮平对精神分裂症患者糖脂代谢的影响[J].临床心身疾病杂志,2016,22(1):4-6. 被引量:2
-
8赵献民.齐拉西酮与奥氮平对首发精神分裂症患者糖脂代谢的影响[J].临床心身疾病杂志,2017,23(2):14-15. 被引量:11
-
9刘文艳.奥氮平致精神分裂症患者代谢异常指标与血清脂联素的相关性[J].临床心身疾病杂志,2017,23(5):21-23. 被引量:7
-
10程君,夏守翠,汪超,高国庆,庞良俊.氨磺必利与利培酮对女性首发精神分裂症患者生化指标的影响[J].临床心身疾病杂志,2017,23(4):28-30. 被引量:5
引证文献1
-
1张炳奎,于纪泽,郭春光,顾卫强,孟彬,赵若莲,陈颖,李艳,李国琼,万芳.精神分裂症患者血清一氧化氮与血糖血脂水平的相关性[J].临床心身疾病杂志,2020,26(2):21-22. 被引量:1
-
1张小婵,程浩,黄河.60岁以上人群踝臂指数与颈动脉粥样硬化斑块相关性研究[J].中国误诊学杂志,2008,8(12):2858-2859. 被引量:1
-
2杨高怡,张莹,倪卫东,李军.难治性肺结核患者血管内皮功能的超声评价[J].浙江中西医结合杂志,2010,20(7):431-432. 被引量:1
-
3张翔(编译).原发感染期间与HIV相关的B细胞功能异常[J].传染病网络动态,2006(3):11-11.
-
4秦学贤.中西医结合治疗5例肠系膜血管闭塞性疾患[J].北京中医,1997,16(1):35-36.
-
5张春阳,邹俊杰,石勇铨,曲卫,夏凌,王怀清,陈峰,刘志民.α硫辛酸改善糖尿病大鼠肾皮质内皮细胞功能[J].中华肾脏病杂志,2008,24(5):361-362. 被引量:2
-
6王华亭,蔡生业,姚成芳.血管平滑肌细胞增殖相关因素的研究进展[J].国外医学(老年医学分册),2002,23(1):23-25. 被引量:2
-
7贾朝江,刘永波,李志光,张雷,刘毅,李金萍,梅昕.经皮动脉内溶栓治疗外周动脉阻塞性病变[J].兵团医学,2008(2):24-25.
-
8宋秉春,张金国.心肌纤维化发病机制及治疗进展[J].济宁医学院学报,2015,38(1):65-67. 被引量:17
-
9余燕敏,冯继明,余红.己酮可可碱治疗糖尿病足的临床观察[J].辽宁药物与临床,2002,5(1):18-19. 被引量:6
-
10张亚兴,王志刚,许川山.声动力学疗法与血管成形术后再狭窄[J].临床超声医学杂志,2007,9(6):358-360.